MedPath

EISAI LIMITED

🇮🇪Ireland
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations

Phase 3
Terminated
Conditions
Parkinson's Disease
Interventions
First Posted Date
2007-07-23
Last Posted Date
2016-01-21
Lead Sponsor
Eisai Limited
Target Recruit Count
328
Registration Number
NCT00505622
Locations
🇫🇷

Centre d'Investigation Clinique, Hospital Purpan, Toulouse, Toulouse Cedex, France

A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours

Phase 1
Suspended
Conditions
Cancer
Interventions
First Posted Date
2007-04-13
Last Posted Date
2009-03-24
Lead Sponsor
Eisai Limited
Target Recruit Count
40
Registration Number
NCT00459823
Locations
🇳🇱

Department of Medical Oncology, Erasmus University Medical Centre, Rotterdam, Netherlands

🇪🇸

Medical Oncology Service. Vall d'Hebron University Hospital, Barcelona, Spain

Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Phase 3
Terminated
Conditions
Parkinson's Disease
Interventions
Drug: Placebo
First Posted Date
2006-08-04
Last Posted Date
2014-07-11
Lead Sponsor
Eisai Limited
Target Recruit Count
723
Registration Number
NCT00360308
Locations
🇫🇷

Pavillon Riser- Hopital Purpan, Toulouse Cedex, France

The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Phase 3
Completed
Conditions
Parkinson's Disease
First Posted Date
2006-02-06
Last Posted Date
2015-11-03
Lead Sponsor
Eisai Limited
Target Recruit Count
702
Registration Number
NCT00286897
Locations
🇦🇹

University Clinic Innsbruck, Innsbruck, Austria

🇦🇹

Department of Neurology, Vienna, Austria

🇧🇪

Cliniques Universitaires St-Luc, Brussels, Belgium

and more 102 locations

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

Phase 2
Completed
Conditions
Spasmodic Torticollis
Interventions
Drug: E2014 (Botulinum toxin type B)
Drug: E2014 (Botulinum toxin type B) Placebo
First Posted Date
2006-01-23
Last Posted Date
2013-04-25
Lead Sponsor
Eisai Limited
Target Recruit Count
48
Registration Number
NCT00280384

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

Phase 4
Completed
Conditions
Epilepsy
First Posted Date
2005-09-22
Last Posted Date
2016-01-08
Lead Sponsor
Eisai Limited
Target Recruit Count
1000
Registration Number
NCT00215592
Locations
🇦🇹

Universitatsklinikum fur Neurologie, Innsbruck, Austria

🇩🇰

Danish Epilepsy Center, Dianalund, Denmark

🇩🇰

The Epilepsy Clinic, Glostrup, Denmark

and more 30 locations

An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine

Phase 2
Terminated
Conditions
Metastatic Breast Cancer
First Posted Date
2005-09-14
Last Posted Date
2014-07-01
Lead Sponsor
Eisai Limited
Target Recruit Count
62
Registration Number
NCT00165880
Locations
🇩🇪

Charite Universitatsmedizin Berlin, Berlin, Germany

🇩🇪

Stadt Kliniken Frankfurt-Hochst, Frankfurt, Germany

🇩🇪

IORC Gmbh, Hamburg, Germany

and more 29 locations

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer (CRC)
First Posted Date
2005-09-14
Last Posted Date
2014-06-27
Lead Sponsor
Eisai Limited
Target Recruit Count
46
Registration Number
NCT00165854
Locations
🇫🇷

Centre Léon Bérard, Lyon, France

🇫🇷

Institut Curie, Paris, France

🇩🇪

Universitätsklinikum der GHS-Essen, Essen, Germany

and more 1 locations

Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)

Phase 4
Completed
Conditions
Osteoporosis
First Posted Date
2005-09-14
Last Posted Date
2010-01-29
Lead Sponsor
Eisai Limited
Registration Number
NCT00165607

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

Phase 3
Completed
Conditions
Dementia With Parkinson's Disease
First Posted Date
2005-09-14
Last Posted Date
2013-05-10
Lead Sponsor
Eisai Limited
Registration Number
NCT00165815
Locations
🇩🇪

Allgemeines Krankenhaus Barmbeck, Hamburg, Hambug, Germany

🇩🇪

Parkinson Klinik Wolfach, Wolfach, Germany

🇮🇪

Belfast City Hospital, Belfast, Ireland

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath